Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

505 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996.
Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Overgaard J, et al. Among authors: dahl o. Int J Hyperthermia. 2009 Aug;25(5):323-34. doi: 10.1080/02656730903091986. Int J Hyperthermia. 2009. PMID: 19670088 No abstract available.
Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.
Westermann A, Mella O, Van Der Zee J, Jones EL, Van Der Steen-Banasik E, Koper P, Uitterhoeve AL, De Wit R, Van Der Velden J, Burger C, Schem BC, Van Der Wilt C, Dahl O, Prosnitz LR, Van Tinteren H. Westermann A, et al. Among authors: dahl o. Int J Hyperthermia. 2012;28(6):549-53. doi: 10.3109/02656736.2012.673047. Epub 2012 Jul 13. Int J Hyperthermia. 2012. PMID: 22788973 Clinical Trial.
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor.
Borkamo ED, Dahl O, Bruland O, Fluge Ø. Borkamo ED, et al. Among authors: dahl o. Int J Hyperthermia. 2009 Feb;25(1):41-6. doi: 10.1080/02656730802397955. Int J Hyperthermia. 2009. PMID: 19219699
2008 ESHO-BSD Award Winner--Gerard C. van Rhoon.
Dahl O. Dahl O. Int J Hyperthermia. 2008 Aug;24(5):444-5. doi: 10.1080/02656730802383997. Int J Hyperthermia. 2008. PMID: 18716944 No abstract available.
Editorial: clinical hyperthermia combined with radiation is safe.
Dahl O. Dahl O. Int J Hyperthermia. 2005 May;21(3):193-7. doi: 10.1080/02656730500069559. Int J Hyperthermia. 2005. PMID: 16019847 No abstract available.
Current status of antivascular therapy and targeted treatment in the clinic.
Dahl O, Borkamo ED, Fluge O. Dahl O, et al. Int J Hyperthermia. 2008 Feb;24(1):97-110. doi: 10.1080/02656730701824406. Int J Hyperthermia. 2008. PMID: 18214773 Review.
Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model.
Borkamo ED, Dahl O, Bruland O, Fluge O. Borkamo ED, et al. Among authors: dahl o. Int J Hyperthermia. 2008 Aug;24(5):425-41. doi: 10.1080/02656730802081997. Int J Hyperthermia. 2008. PMID: 18608572
Quality assurance for radiofrequency regional hyperthermia.
Hornsleth SN, Frydendal L, Mella O, Dahl O, Raskmark P. Hornsleth SN, et al. Among authors: dahl o. Int J Hyperthermia. 1997 Mar-Apr;13(2):169-85. doi: 10.3109/02656739709012381. Int J Hyperthermia. 1997. PMID: 9147144
Hyperthermia exhibits anti-vascular activity in the s.c. BT4An rat glioma: lack of interaction with the angiogenesis inhibitor batimastat.
Eikesdal HP, Bjorkhaug ST, Dahl O. Eikesdal HP, et al. Among authors: dahl o. Int J Hyperthermia. 2002 Mar-Apr;18(2):141-52. doi: 10.1080/02656730110090712. Int J Hyperthermia. 2002. PMID: 11911484
Referee: hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer.
Dahl O, Mella O. Dahl O, et al. Int J Hyperthermia. 2002 Jan-Feb;18(1):25-30. doi: 10.1080/02656730110083756. Int J Hyperthermia. 2002. PMID: 11820464 Review.
505 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback